Published in Transl Pediatr on January 01, 2016
Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA (2012) 5.10
Neonatal drug withdrawal. Pediatrics (2012) 2.86
Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA (2013) 2.34
Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction (2010) 1.71
Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol (2006) 1.61
Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr (2013) 1.57
Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med (2015) 1.48
Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol (2014) 1.28
Neonatal abstinence syndrome. Pediatrics (2014) 1.22
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics (2008) 1.18
Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract (2014) 1.17
Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011. J Perinatol (2014) 1.13
A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics (2014) 1.11
Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J Perinatol (2011) 0.99
The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. J Addict Med (2011) 0.98
Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol (2015) 0.95
Neonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National Survey. Hosp Pediatr (2013) 0.89
Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population. Popul Health Manag (2015) 0.86
Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome. Clin Pharmacol Ther (2014) 0.81
Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome. J Pediatr (2015) 0.81
Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend (2015) 0.80
Implementation of a Neonatal Abstinence Syndrome Weaning Protocol: A Multicenter Cohort Study. Pediatrics (2015) 0.80
Formulation of buprenorphine for sublingual use in neonates. J Pediatr Pharmacol Ther (2011) 0.78